228 related articles for article (PubMed ID: 31768522)
21. Incidence, persistence, and clearance of anogenital human papillomavirus among men who have sex with men in Taiwan: a community cohort study.
Zhou X; Tian T; Lu Z; Yu YF; Li Y; Zhou Y; Lin YF; Strong C; Zou H
Front Immunol; 2023; 14():1190007. PubMed ID: 37409111
[TBL] [Abstract][Full Text] [Related]
22. Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women.
Minkoff H; Feldman JG; Strickler HD; Watts DH; Bacon MC; Levine A; Palefsky JM; Burk R; Cohen MH; Anastos K
J Infect Dis; 2004 May; 189(10):1821-8. PubMed ID: 15122518
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.
Beachler DC; Sugar EA; Margolick JB; Weber KM; Strickler HD; Wiley DJ; Cranston RD; Burk RD; Minkoff H; Reddy S; Xiao W; Guo Y; Gillison ML; D'Souza G
Am J Epidemiol; 2015 Jan; 181(1):40-53. PubMed ID: 25480823
[TBL] [Abstract][Full Text] [Related]
24. Incidence, Clearance, and Persistence of Anal Human Papillomavirus in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Implications for Human Papillomavirus Vaccination.
Ong JJ; Walker S; Grulich A; Hoy J; Read TRH; Bradshaw C; Chen M; Garland SM; Cornall A; Hillman R; Templeton DJ; Hocking J; Eu B; Tee BK; Chow EPF; Fairley CK
Sex Transm Dis; 2019 Apr; 46(4):229-233. PubMed ID: 30870323
[TBL] [Abstract][Full Text] [Related]
25. Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections.
Smith-McCune KK; Shiboski S; Chirenje MZ; Magure T; Tuveson J; Ma Y; Da Costa M; Moscicki AB; Palefsky JM; Makunike-Mutasa R; Chipato T; van der Straten A; Sawaya GF
PLoS One; 2010 Apr; 5(4):e10094. PubMed ID: 20386706
[TBL] [Abstract][Full Text] [Related]
26. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
27. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
[TBL] [Abstract][Full Text] [Related]
28. Time trend analysis of cervical high-risk human papillomavirus (HPV) in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil: the rise of non-16/18 HPV.
Cambou MC; Levi JE; Lake JE; de Andrade A; Jalil EM; Russomano F; Derrico M; Veloso VG; Friedman RK; Luz PM; Grinsztejn B
Int J Infect Dis; 2015 Dec; 41():17-20. PubMed ID: 26518062
[TBL] [Abstract][Full Text] [Related]
29. Correlates of sexual activity and sexually transmitted infections among human immunodeficiency virus-infected youth in the LEGACY cohort, United States, 2006.
Setse RW; Siberry GK; Gravitt PE; Moss WJ; Agwu AL; Wheeling JT; Bohannon BA; Dominguez KL;
Pediatr Infect Dis J; 2011 Nov; 30(11):967-73. PubMed ID: 22001904
[TBL] [Abstract][Full Text] [Related]
30. Type-specific incidence, persistence and factors associated with human papillomavirus infection among female sex workers in Benin and Mali, West Africa.
Tounkara FK; Téguété I; Guédou FA; Talbot D; Traoré CB; Béhanzin L; Traoré S; Goma-Matsétsé E; Aza-Gnandji M; Keita B; Guenoun J; Coutlée F; Alary M
Int J Infect Dis; 2021 May; 106():348-357. PubMed ID: 33848674
[TBL] [Abstract][Full Text] [Related]
31. Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization.
Liu G; Mugo NR; Brown ER; Mgodi NM; Chirenje ZM; Marrazzo JM; Winer RL; Mansoor L; Palanee-Phillips T; Siva SS; Naidoo L; Jeenarain N; Gaffoor Z; Nair GL; Selepe P; Nakabiito C; Mkhize B; Mirembe BG; Taljaard M; Panchia R; Baeten JM; Balkus JE; Hladik F; Celum CL; Barnabas RV
AIDS; 2022 Feb; 36(2):257-265. PubMed ID: 34172672
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania.
Dartell M; Rasch V; Munk C; Kahesa C; Mwaiselage J; Iftner T; Kjaer SK
Sex Transm Dis; 2013 Sep; 40(9):737-43. PubMed ID: 23949589
[TBL] [Abstract][Full Text] [Related]
33. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
[TBL] [Abstract][Full Text] [Related]
34. Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study.
Patel P; Bush T; Conley L; Unger ER; Darragh TM; Henry K; Escota G; Brooks JT; Kojic EM
J Infect Dis; 2020 Jun; 222(2):234-242. PubMed ID: 31536120
[TBL] [Abstract][Full Text] [Related]
35. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.
Shrestha S; Sudenga SL; Smith JS; Bachmann LH; Wilson CM; Kempf MC
BMC Infect Dis; 2010 Oct; 10():295. PubMed ID: 20946655
[TBL] [Abstract][Full Text] [Related]
36. Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study.
Zou H; Tabrizi SN; Grulich AE; Hocking JS; Bradshaw CS; Cornall AM; Morrow A; Prestage G; Law MG; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2015 Jan; 15(1):65-73. PubMed ID: 25435055
[TBL] [Abstract][Full Text] [Related]
37. Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
Ramanakumar AV; Naud P; Roteli-Martins CM; de Carvalho NS; de Borba PC; Teixeira JC; Blatter M; Moscicki AB; Harper DM; Romanowski B; Tyring SK; Ramjattan B; Schuind A; Dubin G; Franco EL;
BMJ Open; 2016 Aug; 6(8):e011371. PubMed ID: 27566633
[TBL] [Abstract][Full Text] [Related]
38. Incidence, clearance, and factors associated with anal human papilloma virus infection among men with HIV.
Zhang J; Sun Y; Chen X; Ye Y; Shen W; Ye X; Lin Y; Lin Z; Tan S; Gao M; Ding Y; He N; Lin H; Liu X
AIDS; 2024 Jan; 38(1):9-20. PubMed ID: 37861684
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and incidence of anal human papillomavirus infection in Mexican men: Need for universal prevention policies.
Posso H; León-Maldonado L; Allen-Leigh B; Salmerón J; Quiterio M; Giuliano AR; Sudenga SL; Nyitray AG; Torres BN; Abrahamsen M; Lazcano-Ponce E
Salud Publica Mex; 2018; 60(6):645-652. PubMed ID: 30699269
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
